Should I go on Mounjaro? Here's how to think it through

The biggest misconception: Mounjaro is only for people who've 'tried everything'

Many people arrive at this question carrying a quiet belief that a medicine like Mounjaro is reserved for a last resort, that you need to have failed every diet, completed a gym programme, and earned the prescription through suffering first. That is not what the clinical evidence or the UK licence says.

Mounjaro is licensed in the UK for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. The medicine works by mimicking two gut hormones (GIP and GLP-1) that regulate appetite and slow the rate at which the stomach empties. It does not require a prior failure history. It requires a clinical assessment.

The evidence is substantial. SURMOUNT-1, published in the New England Journal of Medicine, followed 2,539 adults with obesity over 72 weeks and found average weight loss of around 20–21% at the 15mg dose. That is not a number drawn from a small or short study. The question is not whether the medicine works, it is whether it is appropriate for you.

Obesity is a condition shaped by biology and hormones, not by a deficit of effort. Reaching for a licensed, clinically supervised treatment is not giving up on willpower. It is treating a health condition with the tools available.

What a prescriber is actually weighing up when they assess you

A prescriber reviewing your Mounjaro consultation is looking at several things at once. BMI is the starting point, not the whole picture. They will consider your existing medical conditions, any medicines you already take, your plans around pregnancy, and whether there are contraindications in your history.

Some situations require particular care. Women using oral contraceptives starting Mounjaro should add a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because the medicine slows gastric emptying in a way that can reduce how much of the pill is absorbed. NHS England's guidance on weight-management injections also advises discussing transdermal HRT (patches or gels) if you are on hormone replacement therapy, for the same reason.

Mounjaro is not recommended during pregnancy, breastfeeding, or when actively trying to conceive. It is not licensed for under-18s. A history of medullary thyroid carcinoma or a condition called MEN2 is a contraindication. Pancreatitis and certain gastrointestinal conditions require careful discussion.

None of this means you are automatically unsuitable. It means those questions need answering before a prescription is written, which is exactly what a same-day clinical review at a regulated service is for. If you are weighing up the process and costs involved, our guide to Mounjaro pricing covers what a private prescription typically includes.

Timing, motivation, and the practical side of starting

People often ask about Mounjaro at a specific moment, after a health check, after a birthday, sometimes at the start of a new month when the numbers feel manageable. One question our prescribers hear often is whether there is a 'right time' to start. Practically speaking, the medicine is taken once a week, and the pen stays in the fridge between doses, so the rhythm fits most routines once you settle in.

Treatment begins at 2.5mg, a dose chosen to let your system adjust rather than to produce the full therapeutic effect straight away. Dose increases happen gradually, reviewed by a prescriber at each stage. The process is incremental by design.

If you are thinking about the NHS route, the current NHS access criteria are strict and phased, with cohorts opening gradually through 2025 and 2026. Many people who are clinically suitable under the licence do not yet meet the NHS eligibility thresholds. A private prescription through a regulated pharmacy is the legal alternative, subject to clinical suitability, which a prescriber decides.

The broader question of whether Mounjaro is the right medicine for your situation involves comparing it with other licensed options, including Wegovy. That comparison is worth making with a prescriber who knows your full picture, not a side-by-side chart alone. Our weight-loss treatment overview sets out what is currently licensed in the UK if you want a starting point.

Side effects: the ones worth knowing about before you decide

Going into a treatment decision with a clear picture of likely side effects is reasonable. For Mounjaro, the most commonly reported ones are gastrointestinal: nausea, loose stools, constipation, reflux, and burping. These are most noticeable in the early weeks or after a dose increase, and for most people they settle.

Less common but more urgent: if you develop severe, persistent stomach pain that radiates towards your back, with or without vomiting, seek medical help promptly. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, infrequent but potentially serious side effect across GLP-1 medicines. It does not mean pancreatitis is likely, it means you should know the warning signs.

Injection-site reactions, fatigue, and headache appear in the data too, generally mild. You can report any suspected side effects through the MHRA's Yellow Card scheme. Before starting, reading the Patient Information Leaflet is genuinely useful, and if you are still working out whether this treatment suits your circumstances, our guide to whether Mounjaro is right for you covers the key questions to think through before you speak to a prescriber. Questions about managing specific foods or habits on treatment, like eating chocolate on Mounjaro, come up more than you might expect and are worth exploring.

Side effects are one factor in the decision. They sit alongside the trial evidence, your health profile, and what a prescriber concludes about your individual suitability. That conversation is where the real assessment happens.